title: Serum creatinine changes in HIV-seropositive patients receiving tenofovir.
authors.forename: Hana M
authors.initials: HM
authors.lastname: El Sahly
authors.forename: Larry
authors.initials: L
authors.lastname: Teeter
authors.forename: Teddy
authors.initials: T
authors.lastname: Zerai
authors.forename: Roberto A
authors.initials: RA
authors.lastname: Andrade
authors.forename: Cesar
authors.initials: C
authors.lastname: Munoz
authors.forename: Calista
authors.initials: C
authors.lastname: Nnabuife
authors.forename: Rodney
authors.initials: R
authors.lastname: Hunter
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood / Q000139:chemically induced*; D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003404:Creatinine / Q000097:blood*; D003430:Cross-Sectional Studies; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D063065:Organophosphonates / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D003404:Creatinine; D000225:Adenine